About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Psoriasis Clinical Trials in Philadelphia | 26 Studies

Clinical Trials PsoriasisPhiladelphia

Psoriasis Clinical Trials in Philadelphia

Find 26 clinical trials for psoriasis near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Psoriasis trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-26 of 26 trials

CompletedEfficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.This clinical study will test the effects of a drug called apremilast in oligoarticular psoriatic arthritis with less than 5 years of disease duration.NCT03747939·Mesa, Arizona and 113 others

Psoriasis Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedPET/CT in Psoriatic ArthritisWhen patients with psoriasis develop joint pain, it is often hard to decide whether or not the pain is due to psoriatic arthritis (PsA).NCT01654198·Philadelphia, Pennsylvania

Active not recruitingA Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisThe purpose of this study is to evaluate how well the study drug JNJ-88545223 works compared with a placebo (an inactive substance) in adults with active psoriatic arthritis (PsA).NCT07321873·Searcy, Arkansas and 74 others

Active not recruitingGuselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsThe trial is an open-label randomized study that will examine whether switching to a selective IL23 inhibitor (guselkumab) is more effective than switching to a second TNFi…NCT05669833·Loxahatchee Groves, Florida and 13 others

TerminatedStudy to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD TherapyThe primary objective of this study is to evaluate the effect of filgotinib compared to placebo as assessed by the American College of Rheumatology 20% improvement (ACR20)…NCT04115839·Covina, California and 58 others

CompletedStepping Up For Inflammatory ArthritisThis study will examine the benefits of a monitored physical activity program for participants with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) using a wearable…NCT02912221·Philadelphia, Pennsylvania

PreviousPage 2 of 2

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia